ropivacaine has been researched along with Pulmonary Edema in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beck-Schimmer, B; Borgeat, A; Castellon, M; Chignalia, AZ; Dull, RO; Hu, G; Koshy, RG; Minshall, RD; Piegeler, T; Schwartz, DE; Votta-Velis, EG | 1 |
1 other study(ies) available for ropivacaine and Pulmonary Edema
Article | Year |
---|---|
Ropivacaine attenuates endotoxin plus hyperinflation-mediated acute lung injury via inhibition of early-onset Src-dependent signaling.
Topics: Acute Lung Injury; Amides; Anesthetics, Local; Animals; Caveolin 1; Disease Models, Animal; Endothelial Cells; Humans; Inflammation; Intercellular Adhesion Molecule-1; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mice, Knockout; Phosphorylation; Pulmonary Edema; Ropivacaine; Signal Transduction; src-Family Kinases; Ventilator-Induced Lung Injury | 2014 |